Apex Biotechnology Corp (1733) — Financial Flexibility Index
Apex Biotechnology Corp (1733) has a Financial Flexibility Index of 0.02x as of September 2025. Free cash flow of NT$8.16 Million (operating CF NT$5.19 Million minus capex NT$2.97 Million) represents 0% of total liabilities (NT$494.69 Million). Check Apex Biotechnology Corp strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Apex Biotechnology Corp Financial Flexibility Index (2002–2024)
Historical Financial Flexibility Index trend for Apex Biotechnology Corp across 23 annual periods. See 1733 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Apex Biotechnology Corp (2002–2024)
Year-by-year free cash flow to debt coverage for Apex Biotechnology Corp. For the full company profile including market capitalisation, see Apex Biotechnology Corp (1733) total market value.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.60x | NT$358.30 Million | NT$328.67 Million | NT$595.70 Million | ▲ +17.8% |
| 2023 | 0.51x | NT$255.37 Million | NT$230.39 Million | NT$500.07 Million | ▲ +432.6% |
| 2022 | 0.10x | NT$66.82 Million | NT$26.62 Million | NT$696.81 Million | ▼ -57.3% |
| 2021 | 0.22x | NT$206.07 Million | NT$179.87 Million | NT$916.91 Million | ▼ -31.3% |
| 2020 | 0.33x | NT$328.93 Million | NT$280.60 Million | NT$1.01 Billion | ▼ -28.3% |
| 2019 | 0.46x | NT$519.11 Million | NT$462.52 Million | NT$1.14 Billion | ▲ +188.1% |
| 2018 | 0.16x | NT$142.85 Million | NT$67.57 Million | NT$901.70 Million | ▲ +68.0% |
| 2017 | 0.09x | NT$97.59 Million | NT$70.83 Million | NT$1.03 Billion | ▼ -78.5% |
| 2016 | 0.44x | NT$336.51 Million | NT$298.06 Million | NT$768.49 Million | ▼ -32.9% |
| 2015 | 0.65x | NT$498.81 Million | NT$472.15 Million | NT$764.69 Million | ▲ +52.5% |
| 2014 | 0.43x | NT$333.02 Million | NT$267.60 Million | NT$778.52 Million | ▼ -53.1% |
| 2013 | 0.91x | NT$732.45 Million | NT$484.77 Million | NT$803.47 Million | ▼ -27.5% |
| 2012 | 1.26x | NT$924.37 Million | NT$509.67 Million | NT$735.18 Million | ▲ +40.4% |
| 2011 | 0.90x | NT$348.08 Million | NT$273.45 Million | NT$388.76 Million | ▼ -54.2% |
| 2010 | 1.95x | NT$626.64 Million | NT$465.59 Million | NT$320.60 Million | ▲ +27.6% |
| 2009 | 1.53x | NT$464.62 Million | NT$391.29 Million | NT$303.31 Million | ▼ -21.1% |
| 2008 | 1.94x | NT$429.70 Million | NT$299.96 Million | NT$221.21 Million | ▼ -5.1% |
| 2007 | 2.05x | NT$419.34 Million | NT$364.62 Million | NT$204.80 Million | ▼ -1.2% |
| 2006 | 2.07x | NT$405.70 Million | NT$363.71 Million | NT$195.73 Million | ▲ +57.8% |
| 2005 | 1.31x | NT$293.44 Million | NT$212.14 Million | NT$223.36 Million | ▼ -64.0% |
| 2004 | 3.65x | NT$469.70 Million | NT$218.54 Million | NT$128.64 Million | ▲ +24.3% |
| 2003 | 2.94x | NT$358.46 Million | NT$302.25 Million | NT$122.00 Million | ▲ +86.4% |
| 2002 | 1.58x | NT$140.62 Million | NT$79.49 Million | NT$89.21 Million | — |